Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.
Details
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_9FEAE9F52639
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.
Journal
Pediatric Nephrology
ISSN
0931-041X (Print)
ISSN-L
0931-041X
Publication state
Published
Issued date
2006
Volume
21
Number
2
Pages
301-302
Language
english
Notes
Publication types: Case Reports ; LetterPublication Status: ppublish. PDF type: LETTER TO THE EDITORS
Abstract
Alteplase has been shown to be effective in preventing central venous access clotting in patients on hemodialysis. Because of a high phosphorus content in its excipient, it can inadvertently contaminate blood samples, leading the physician in care of the patient to erroneously increase dialysis time or change diet in order to control the pseudo-hyperphosphatemia.
Keywords
Catheterization, Central Venous/instrumentation, Child, Preschool, Fibrinolytic Agents/adverse effects, Humans, Male, Phosphorus Metabolism Disorders/chemically induced, Renal Dialysis/instrumentation, Tissue Plasminogen Activator/adverse effects
Pubmed
Web of science
Open Access
Yes
Create date
24/04/2013 11:28
Last modification date
14/02/2022 8:56
Usage data
